Illustration: Craig Stephens
Illustration: Craig Stephens
Zha Daojiong
Opinion

Opinion

Zha Daojiong

WHO’s Sinopharm approval opens the door to distributing Chinese vaccines abroad

  • In addition to dealing with spikes in India and Brazil, countries that border China should also receive priority for Chinese vaccines
  • Being active in Covax and other multilateral channels can help overcome geopolitical hurdles and ensure access to more foreign markets in the future

Illustration: Craig Stephens
Illustration: Craig Stephens
READ FULL ARTICLE